Иммунологическая эффективность массовой вакцинопрофилактики против гепатита в в рамках реализации приоритетного Национального проекта "Здоровье" в отдельных регионах Российской Федерации

Шулакова Надежда Ивановна, И Н Лыткина, В. Г. Акимкин et al. · Epidemiology and Infectious Diseases · 2015

Immunological efficacy of mass vaccine prevention of hepatitis B was studied in the framework of the National Priority Project Health in some regions of the Russian Federation. Markers of hepatitis B (HbsAg, anti-HBs with the determination of their concentration, anti-HBcor summary and class IgM) were determined with the use of commercial test systems by chemiluminescence enzyme immunoassay analyzer the Architect of the company «Abbott» (USA) at different times after the completion of vaccination

Cited by 1 works.

Authors